• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源 M2 毒蕈碱型乙酰胆碱受体与拮抗剂结合的结构。

Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist.

机构信息

Department of Life Science, Faculty of Science, Gakushuin University, Mejiro 1-5-1, Tokyo 171-8588, Japan.

出版信息

Nature. 2012 Jan 25;482(7386):547-51. doi: 10.1038/nature10753.

DOI:10.1038/nature10753
PMID:22278061
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3345277/
Abstract

The parasympathetic branch of the autonomic nervous system regulates the activity of multiple organ systems. Muscarinic receptors are G-protein-coupled receptors that mediate the response to acetylcholine released from parasympathetic nerves. Their role in the unconscious regulation of organ and central nervous system function makes them potential therapeutic targets for a broad spectrum of diseases. The M2 muscarinic acetylcholine receptor (M2 receptor) is essential for the physiological control of cardiovascular function through activation of G-protein-coupled inwardly rectifying potassium channels, and is of particular interest because of its extensive pharmacological characterization with both orthosteric and allosteric ligands. Here we report the structure of the antagonist-bound human M2 receptor, the first human acetylcholine receptor to be characterized structurally, to our knowledge. The antagonist 3-quinuclidinyl-benzilate binds in the middle of a long aqueous channel extending approximately two-thirds through the membrane. The orthosteric binding pocket is formed by amino acids that are identical in all five muscarinic receptor subtypes, and shares structural homology with other functionally unrelated acetylcholine binding proteins from different species. A layer of tyrosine residues forms an aromatic cap restricting dissociation of the bound ligand. A binding site for allosteric ligands has been mapped to residues at the entrance to the binding pocket near this aromatic cap. The structure of the M2 receptor provides insights into the challenges of developing subtype-selective ligands for muscarinic receptors and their propensity for allosteric regulation.

摘要

自主神经系统的副交感分支调节多个器官系统的活动。毒蕈碱受体是 G 蛋白偶联受体,介导来自副交感神经释放的乙酰胆碱的反应。它们在器官和中枢神经系统功能的无意识调节中的作用使它们成为广泛疾病的潜在治疗靶点。M2 毒蕈碱乙酰胆碱受体 (M2 受体) 通过激活 G 蛋白偶联内向整流钾通道对心血管功能的生理控制至关重要,并且由于其广泛的药理学特征,包括正位和变构配体,因此特别有趣。在这里,我们报告了与拮抗剂结合的人类 M2 受体的结构,据我们所知,这是第一个被结构特征化的人类乙酰胆碱受体。拮抗剂 3-奎宁环基苯甲酰基结合在延伸穿过膜约三分之二的长水通道的中间。正位结合口袋由在所有五种毒蕈碱受体亚型中都相同的氨基酸形成,并且与来自不同物种的其他功能上无关的乙酰胆碱结合蛋白具有结构同源性。一层酪氨酸残基形成一个芳香帽,限制结合配体的解离。变构配体的结合位点已映射到位于该芳香帽附近的结合口袋入口处的残基上。M2 受体的结构提供了对开发毒蕈碱受体亚型选择性配体的挑战以及它们对变构调节的倾向的深入了解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b52/3345277/fc43fc6e2c37/nihms341767f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b52/3345277/22a8934825fd/nihms341767f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b52/3345277/5b400713b122/nihms341767f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b52/3345277/1cb08b7bb868/nihms341767f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b52/3345277/fc43fc6e2c37/nihms341767f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b52/3345277/22a8934825fd/nihms341767f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b52/3345277/5b400713b122/nihms341767f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b52/3345277/1cb08b7bb868/nihms341767f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b52/3345277/fc43fc6e2c37/nihms341767f4.jpg

相似文献

1
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist.人源 M2 毒蕈碱型乙酰胆碱受体与拮抗剂结合的结构。
Nature. 2012 Jan 25;482(7386):547-51. doi: 10.1038/nature10753.
2
Structural biology: Muscarinic receptors become crystal clear.结构生物学:毒蕈碱受体变得清晰明了。
Nature. 2012 Feb 22;482(7386):480-1. doi: 10.1038/482480a.
3
Role of Conserved Tyrosine Lid Residues in the Activation of the M Muscarinic Acetylcholine Receptor.保守的酪氨酸盖残基在 M 毒蕈碱型乙酰胆碱受体激活中的作用。
Mol Pharmacol. 2023 Sep;104(3):92-104. doi: 10.1124/molpharm.122.000661. Epub 2023 Jun 22.
4
Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias.鉴定 M2 毒蕈碱乙酰胆碱受体的变构和变构部位突变,这些突变导致配体选择性信号转导偏倚。
J Biol Chem. 2010 Mar 5;285(10):7459-74. doi: 10.1074/jbc.M109.094011. Epub 2010 Jan 5.
5
Graded activation and free energy landscapes of a muscarinic G-protein-coupled receptor.毒蕈碱型 G 蛋白偶联受体的分级激活与自由能景观
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12162-12167. doi: 10.1073/pnas.1614538113. Epub 2016 Oct 10.
6
Ligand-Triggered Structural Changes in the M Muscarinic Acetylcholine Receptor.激动剂诱导的 M 型乙酰胆碱受体的结构变化。
J Chem Inf Model. 2018 May 29;58(5):1074-1082. doi: 10.1021/acs.jcim.8b00108. Epub 2018 May 2.
7
Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.开发一种放射性配体 [(3)H]LY2119620,以探测人源 M(2)和 M(4)毒蕈碱型乙酰胆碱受体变构结合位点。
Mol Pharmacol. 2014 Jul;86(1):116-23. doi: 10.1124/mol.114.091785. Epub 2014 May 7.
8
A model of the human M2 muscarinic acetylcholine receptor.人M2型毒蕈碱型乙酰胆碱受体模型
J Comput Aided Mol Des. 2002 Nov;16(11):795-801. doi: 10.1023/a:1023880611709.
9
Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.M2 型乙酰胆碱受体中的变构位点:正构激动剂而非拮抗剂结合后发生重大构象变化的证据。
Naunyn Schmiedebergs Arch Pharmacol. 2006 Jan;372(4):267-76. doi: 10.1007/s00210-005-0023-4. Epub 2005 Dec 16.
10
Structural insights into the subtype-selective antagonist binding to the M muscarinic receptor.结构洞察亚型选择性拮抗剂与 M 毒蕈碱受体的结合。
Nat Chem Biol. 2018 Dec;14(12):1150-1158. doi: 10.1038/s41589-018-0152-y. Epub 2018 Nov 12.

引用本文的文献

1
Decoding the limits of deep learning in molecular docking for drug discovery.解码深度学习在药物发现分子对接中的局限性。
Chem Sci. 2025 Aug 19. doi: 10.1039/d5sc05395a.
2
Effects of renal denervation at BP-elevation/reduction sites guided by renal nerve stimulation on atrial neural and structural remodeling in a hypertensive canine model.在高血压犬模型中,由肾神经刺激引导在血压升高/降低部位进行肾去神经支配对心房神经和结构重塑的影响。
Hypertens Res. 2025 Jul 10. doi: 10.1038/s41440-025-02258-0.
3
Adiabatic-Bias Molecular Dynamics Simulations Reveal the Impact of Mutations on Muscarinic Antagonist Unbinding Kinetics.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Structure of the human histamine H1 receptor complex with doxepin.人源组胺 H1 受体复合物与多塞平的结构。
Nature. 2011 Jun 22;475(7354):65-70. doi: 10.1038/nature10236.
3
Evaluation of the Pichia pastoris expression system for the production of GPCRs for structural analysis.评估毕赤酵母表达系统生产用于结构分析的 GPCR。
绝热偏置分子动力学模拟揭示突变对毒蕈碱拮抗剂解离动力学的影响。
J Chem Inf Model. 2025 Jul 14;65(13):7129-7142. doi: 10.1021/acs.jcim.5c00601. Epub 2025 Jun 16.
4
From pharmacophore predictions to pharmaceutical possibilities: an integrated approach to screen M selective muscarinic receptor antagonist.从药效团预测到药物研发可能性:筛选M选择性毒蕈碱受体拮抗剂的综合方法
Mol Divers. 2025 May 13. doi: 10.1007/s11030-025-11208-4.
5
Activity cliff-aware reinforcement learning for de novo drug design.用于从头药物设计的活动悬崖感知强化学习
J Cheminform. 2025 Apr 21;17(1):54. doi: 10.1186/s13321-025-01006-3.
6
A New Era of Muscarinic Acetylcholine Receptor Modulators in Neurological Diseases, Cancer and Drug Abuse.毒蕈碱型乙酰胆碱受体调节剂在神经疾病、癌症和药物滥用领域的新时代。
Pharmaceuticals (Basel). 2025 Mar 5;18(3):369. doi: 10.3390/ph18030369.
7
Discovering Key Activation Hotspots in the M Muscarinic Receptor.发现M型毒蕈碱受体中的关键激活热点
J Am Chem Soc. 2025 Apr 9;147(14):11754-11765. doi: 10.1021/jacs.4c14385. Epub 2025 Mar 14.
8
Visualizing agonist-induced M2 receptor activation regulated by aromatic ring dynamics.可视化由芳环动力学调控的激动剂诱导的M2受体激活。
Proc Natl Acad Sci U S A. 2025 Mar 11;122(10):e2418559122. doi: 10.1073/pnas.2418559122. Epub 2025 Mar 7.
9
Comparative in vitro and in silico evaluation of the toxic effects of metformin and/or ascorbic acid, new treatment options in the treatment of Melasma.二甲双胍和/或抗坏血酸对黄褐斑治疗的新选择的毒性作用的体外和计算机模拟比较评估
Toxicol Res (Camb). 2025 Feb 27;14(1):tfaf025. doi: 10.1093/toxres/tfaf025. eCollection 2025 Feb.
10
The Cation-π Interaction in Chemistry and Biology.化学与生物学中的阳离子-π相互作用
Chem Rev. 2025 Mar 12;125(5):2793-2808. doi: 10.1021/acs.chemrev.4c00707. Epub 2025 Feb 20.
Microb Cell Fact. 2011 Apr 22;10:24. doi: 10.1186/1475-2859-10-24.
4
Structure of a nanobody-stabilized active state of the β(2) adrenoceptor.β2 肾上腺素能受体的纳米体稳定的活性状态结构。
Nature. 2011 Jan 13;469(7329):175-80. doi: 10.1038/nature09648.
5
Crystal structures of a cysteine-modified mutant in loop D of acetylcholine-binding protein.D 环半胱氨酸修饰突变乙酰胆碱结合蛋白晶体结构
J Biol Chem. 2011 Feb 11;286(6):4420-8. doi: 10.1074/jbc.M110.188730. Epub 2010 Nov 29.
6
Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist.人源多巴胺 D3 受体与 D2/D3 选择性拮抗剂复合物的结构。
Science. 2010 Nov 19;330(6007):1091-5. doi: 10.1126/science.1197410.
7
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.小分子和环肽拮抗剂与 CXCR4 趋化因子 GPCR 的结构。
Science. 2010 Nov 19;330(6007):1066-71. doi: 10.1126/science.1194396. Epub 2010 Oct 7.
8
Phaser crystallographic software.相位结晶学软件。
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674. doi: 10.1107/S0021889807021206. Epub 2007 Jul 13.
9
Crystallizing membrane proteins using lipidic mesophases.利用脂质中间相结晶膜蛋白。
Nat Protoc. 2009;4(5):706-31. doi: 10.1038/nprot.2009.31.
10
Allosteric modulation of muscarinic acetylcholine receptors.变构调节毒蕈碱型乙酰胆碱受体。
Curr Neuropharmacol. 2007 Sep;5(3):157-67. doi: 10.2174/157015907781695946.